Journey Strategic Wealth LLC Repligen Corp Transaction History

Journey Strategic Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $135,519 - $220,010	1,187 New	1,187 $213,000
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $6,170 - $7,924	-40 Reduced 3.19%	1,214 $204,000
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $5,035 - $6,837	-31 Reduced 2.41%	1,254 $212,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $206,139 - $329,229	1,285 New	1,285 $240,000
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $172,895 - $231,076	-1,229 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $27,402 - $43,853	170 Added 16.05%	1,229 $231,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $262,197 - $322,433	1,059 New	1,059 $280,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.32B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Journey Strategic Wealth LLC with notifications on news.